A novel computational predictive biological approach distinguishes Integrin ß1 as a salient biomarker for breast cancer chemoresistance.
Biochim Biophys Acta Mol Basis Dis
; 1869(6): 166702, 2023 08.
Article
in En
| MEDLINE
| ID: mdl-37044238
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Breast Neoplasms
/
Integrin beta1
Type of study:
Prognostic_studies
/
Risk_factors_studies
Limits:
Female
/
Humans
Language:
En
Journal:
Biochim Biophys Acta Mol Basis Dis
Year:
2023
Type:
Article
Affiliation country:
India